Clinical Implications of Isoniazid Blood Levels in Pulmonary Tuberculosis
- 28 November 1957
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 257 (22) , 1066-1070
- https://doi.org/10.1056/nejm195711282572202
Abstract
ORALLY administered isoniazid is converted to various metabolic derivatives in the human body. Isoniazid hydrazones, acetylated isoniazid, isonicotinic acid and isonicotinic acid conjugates, in addition to free unmetabolized isoniazid, have been found in the urine of human subjects given a single oral test dose of isoniazid.1 This metabolic alteration is so extensive in some cases that as little as 1 per cent of a test dose of the drug may be excreted in the urine free and unaltered, and as much as 60 per cent of a dose may be excreted in the acetylated form. Only the free drug, however, . . .Keywords
This publication has 8 references indexed in Scilit:
- Present-day management of tuberculosisJournal of Chronic Diseases, 1956
- Inhibition of Isoniazid Acetylation in vitro and in vivo.Experimental Biology and Medicine, 1956
- Effect of Para-Aminosalicylic Acid on Serum Isoniazid Levels in ManExperimental Biology and Medicine, 1956
- The metabolism of p‐aminosalicylic acid (PAS) in manJournal of the American Pharmaceutical Association (Scientific ed.), 1955
- EARLY RESULTS OF PROLONGED STREPTOMYCINPAS TREATMENT OF PULMONARY TUBERCULOSISAnnals of Internal Medicine, 1954
- ON THE METABOLIC FATE OF ISONIAZID1953
- THE ESTIMATION OF ISONICOTINIC ACID HYDRAZIDE (NYDRAZID) IN BIOLOGIC FLUIDSPublished by Elsevier ,1952
- CHEMOTHERAPY OF EXPERIMENTAL TUBERCULOSIS .5. ISONICOTINIC ACID HYDRAZIDE (NYDRAZID) AND RELATED COMPOUNDSPublished by Elsevier ,1952